| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/30/2008 | CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/30/2008 | CA2215190C Aryl-ester phosphoramidate derivatives of nucleosides |
| 12/30/2008 | CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis |
| 12/30/2008 | CA2162924C New peptide antagonists at glutamate and nmda receptors |
| 12/25/2008 | US20080319067 Acetic acid, 6-(4-chlorophenyl-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-2-yl) ester; nontoxic; high bioavailability; side effect reduction; pharmakinetics;antiallergens; antiinflammatory agents; skin disorders; bronchodilators; asthma; psoriasis; eczema; antiarthritic agents |
| 12/25/2008 | US20080319056 Butylphthalide Self-Emulsifying Drug Delivery System, Its Preparation Method and Application |
| 12/25/2008 | US20080319051 Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| 12/25/2008 | US20080319018 Organic compounds |
| 12/25/2008 | US20080318984 Compounds Having Activity in Correcting Mutant-Cftr Processing and Uses Thereof |
| 12/25/2008 | US20080318975 Prevent transplant rejection |
| 12/25/2008 | US20080318932 Sodium Channel Blocker Compositions and the Use Thereof |
| 12/25/2008 | US20080318921 5R,6Z)-6-(Imidazo[2,1-b][1,3]benzothiazol-2-ylmethylene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid; beta -Lactamases hydrolyze beta -lactam antibiotics and as such serve as the primary cause of bacterial resistance |
| 12/25/2008 | US20080318896 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA |
| 12/25/2008 | US20080318892 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad |
| 12/25/2008 | US20080318883 Anti-aging supplement |
| 12/25/2008 | US20080318856 administering a monomer protein comprising an amino acid sequence belonging to the TGF- beta super family, wherein alanine at position 83 is replaced with a serine, threonine or valine; protein induces differentiation of osteoblasts measured by promoting alkaline phosphatase activity to a patient |
| 12/25/2008 | US20080318839 Ligand activated transcriptional regulator proteins |
| 12/25/2008 | US20080318838 Peptides |
| 12/25/2008 | US20080318293 Sulfotransferase Inhibitors |
| 12/25/2008 | US20080318227 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 12/25/2008 | US20080317865 Quench liquids and washing systems for production of microparticles |
| 12/25/2008 | US20080317864 Chitosan and Heparin Nanoparticles |
| 12/25/2008 | US20080317863 Pharmaceutical Compositions Useful in the Transmucosal Administration of Drugs |
| 12/25/2008 | US20080317851 Immediate release dosage forms containing solid drug disbursions |
| 12/25/2008 | US20080317835 Personalized Nutrient Deficiency Assay Methods |
| 12/25/2008 | US20080317834 Compounds and methods for modulating cerebral amyloid angiopathy |
| 12/25/2008 | US20080317833 Novel Anti-Inflammatory Androstane Derivatives |
| 12/25/2008 | US20080317822 Methods for Delivery of Nanosome Encapsulated Agents |
| 12/25/2008 | US20080317812 Spacer with a coating thereon for use with an implant device |
| 12/25/2008 | US20080317772 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 12/25/2008 | US20080317769 Vaccine Composition Comprising Alpha-Galactosylceramide as an Adjuvant For Intranasal Administration |
| 12/25/2008 | US20080317763 Regulation of Metalloprotease Cleavage of Cell Surface Proteins |
| 12/25/2008 | US20080317759 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 12/25/2008 | US20080317756 Antibodies to Chemokine Alpha-5 |
| 12/25/2008 | US20080317754 Human Osteoclast Derived Cathepsin |
| 12/25/2008 | US20080317731 Phospholipases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 12/25/2008 | US20080317703 Novel Composition for Xerostomia |
| 12/25/2008 | US20080317671 Non-imidazole heterocyclic compounds |
| 12/25/2008 | US20080317670 Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides |
| 12/24/2008 | WO2008157786A1 Substituted n-aryl pyridinones as fibrotic inhibitors |
| 12/24/2008 | WO2008157372A2 Self assembled films for protein and drug delivery applications |
| 12/24/2008 | WO2008156208A1 5-phenyl-3-pyridazinone derivative |
| 12/24/2008 | WO2008156174A1 Pyrazinamide compound |
| 12/24/2008 | WO2008156153A1 Preventive/remedy for cancer |
| 12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 12/24/2008 | WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008155999A1 Gabaergic neuron activator |
| 12/24/2008 | WO2008155920A1 Drug having effect of promoting hepatocyte growth |
| 12/24/2008 | WO2008155390A2 Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases. |
| 12/24/2008 | WO2008155081A2 Substituted aromatic heterocyclic compounds as fungicides |
| 12/24/2008 | WO2008155035A2 Oxazolidinones for the treatment and prophylaxis of sepsis |
| 12/24/2008 | WO2008067549A3 Stabilized zolpidem pharmaceutical compositions |
| 12/24/2008 | WO2007133580A3 Use of pth (1-31) and optionally g-csf for hematopoietic stimulation |
| 12/24/2008 | EP2006380A1 Agonistic antibody directed against human thrombopoietin receptor |
| 12/24/2008 | EP2006300A2 Characterization of a calcium channel family |
| 12/24/2008 | EP2006286A2 Isoxazole derivative and isothiazole derivative having inhibitory activity on 11 beta -hydroxysteroid dehydrogenase type i |
| 12/24/2008 | EP2005954A2 Kit for cancer therapy and pharmaceutical composition for cancer therapy |
| 12/24/2008 | EP2005952A1 Tamsulosin-containing percutaneous absorption type preparation |
| 12/24/2008 | EP2005951A2 Agent for improving nervous system cell functions |
| 12/24/2008 | EP2004179A1 Medicament, cosmetic or food product comprising an indol compound, the use thereof and the method of isolation thereof from sauerkraut |
| 12/24/2008 | EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 12/24/2008 | EP1461306B1 Quaternary ammonium compounds and their use as antimuscarinic agents |
| 12/24/2008 | EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 12/24/2008 | EP1328291B1 Viruses targeted to hypoxic cells and tissues |
| 12/24/2008 | EP1218511B1 Antimicrobial compositions |
| 12/24/2008 | EP1003773B1 Ctl epitopes of epstein-barr virus |
| 12/24/2008 | CN101330920A Liquid medicine for internal use |
| 12/24/2008 | CN101328157A Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 12/24/2008 | CN101328135A Carbonyl phenyl propanoic acid derivative compounds |
| 12/24/2008 | CN101327321A Soft capsules containing lactase |
| 12/24/2008 | CN101327203A Gallic acid chelates composition and uses thereof |
| 12/24/2008 | CN101327200A Glycerol fruit sugar injection and preparation method thereof |
| 12/24/2008 | CN100445380C Therapeutically useful synthetic oligonucleotides |
| 12/24/2008 | CN100445295C 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 12/24/2008 | CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/24/2008 | CN100445270C Pyrimidine compounds |
| 12/24/2008 | CN100445266C MCH antagonists and their use in treatment of obesity |
| 12/24/2008 | CN100444853C Transaminase lowering dripping pill and its prepn |
| 12/24/2008 | CN100444838C Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 12/24/2008 | CN100444837C Novel herbal chemical composition for treatment of cancer |
| 12/24/2008 | CN100444830C Multiparticulate modified release composition |
| 12/24/2008 | CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | CA2691379A1 Substituted n-aryl pyridinones |
| 12/24/2008 | CA2688441A1 Substituted aromatic heterocyclic compounds as fungicides |
| 12/23/2008 | US7468443 central nervous system disorders; regenerating nervous systems |
| 12/23/2008 | US7468380 Nitrogen-containing aromatic derivatives |
| 12/23/2008 | US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
| 12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 12/23/2008 | US7468276 Bloodless mammalian placenta for use in generating multipotent stem cells |
| 12/23/2008 | US7468181 Means and methods for the production of adenovirus vectors |
| 12/23/2008 | US7468179 Aerosol for delivery of naltrexone, buprenorphine, nalbuphine, naloxone, butorphanol, hydromorphone, oxycodone, methadone, remifentanil, sufentanil, or fentanyl by vaporizing the drug, which is coated on support and condensing to form aerosol with mass median aerodynamic diameter of less than 5 microns |
| 12/23/2008 | CA2442557C Dihydro-benzo¬b|¬1,4|diazepin-2-one derivatives as mglur2 antagonists ii |
| 12/23/2008 | CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/23/2008 | CA2326339C Use of dexmedetomidine for icu sedation |
| 12/23/2008 | CA2306393C Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 12/23/2008 | CA2230690C Administration of ketamine to manage pain and to reduce drug dependency |
| 12/18/2008 | WO2008153813A2 Bone augmentation utilizing muscle-derived progenitor compositions, and treatments thereof |